<DOC>
	<DOCNO>NCT00002046</DOCNO>
	<brief_summary>To evaluate pharmacokinetics Retrovir ( AZT ) administer orally 1 3 dos treatment patient severe clinical laboratory manifestation HIV infection . To compare safety tolerance AZT administer 2 , 3 , 6 x daily patient .</brief_summary>
	<brief_title>A Dose-Frequency Trial Oral Retrovir Patients With AIDS Severe ARC</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<criteria>Inclusion Criteria Concurrent Treatment : Allowed : Electron beam therapy area le 100 cm2 . Patients follow excluded : Any immediately lifethreatening infection medical condition present time study entry . Any active opportunistic infection require chronic therapy present time study entry . Patients Pneumocystis carinii pneumonia ( PCP ) may randomize study medication follow minimum 7day course therapy result stabilization disease . Patients stabilized disease must fever &lt; 39 degree C least 48 hour ; oxygen ( room air ) = &gt; 60 mm , arterial / alveolar gradient = &lt; 30 mm . Kaposi 's sarcoma , lymphoma , tumor likely require cytotoxic chemotherapy . Seropositive HIV antibody document federally license ELISA . Patients must ability give informed consent advance HIV disease define : History Pneumocystis carinii pneumonia ( PCP ) histologic verification within 4 month study entry . OR History opportunistic infection include CDC surveillance definition AIDS ( stage IVC1 ) , diagnose within 4 month entry , require chronic suppressive therapy , CD4+ cell count &lt; 200 cells/mm3 . OR AIDS relate complex ( ARC ) patient CD4+ count &lt; 200 cells/mm3 documentation least two sign symptom list . One sign symptom must weight loss candidiasis describe . Unexplained weight loss &gt; 10 percent = &gt; 15 lb within previous 4 month ; low weight entry . History mucocutaneous oral candidiasis ( culture potassium hydroxide KOH smear ) . Fever &gt; 38 degree C , without document infectious cause present , persist &gt; 1 month . Oral hairy leukoplakia . Unexplained night sweat , persist &gt; 1 month . Herpes zoster infection within 3 month entry . Chronic diarrhea unknown infectious etiology persist &gt; 1 month 3 sample do eliminate ovum , parasite , Cryptosporidia , Mycobacterium avium intracellulare , cytomegalovirus ( CMV ) , pathogens associate diarrheal disease AIDS patient . Negative Venereal Disease Research Laboratory ( VDRL ) Rapid Plasma Reagent ( RPR ) , positive verify Fluorescent Treponemal Antibody Absorption ( FTAABS ) , documented history treatment syphilis . If FTAABS positive , treatment history available , patient may enter 3 day follow initiation appropriate chemotherapy . Exclusion Criteria Coexisting Condition : Patients follow exclude : Chronic herpes virus infection . Fever &gt; 39 degree C study entry . Known hypersensitivity lactate and/or gelatin . Kaposi 's sarcoma , lymphoma , tumor likely require cytotoxic chemotherapy . Impaired renal function . AIDS dementia complex . Concurrent Medication : Excluded : Drugs cause significant bone marrow suppression . Rifampin rifampin derivative . Drugs cause significant nephrotoxicity hepatotoxicity . Antiretroviral agent , include ribavirin , dideoxycytidine , dideoxyadenosine , didanosine , foscarnet , dextran sulfate , AL721 . Acyclovir therapy 21 day duration . Concurrent Treatment : Excluded : Radiation therapy ( exception electron beam therapy area le 100 cm2 ) . Experimental therapy . Cytolytic chemotherapy . Prior Medication : Excluded : Acyclovir therapy 21 day duration . Zidovudine ( AZT ) . Excluded within 2 week study entry : Drugs cause significant bone marrow suppression . Rifampin rifampin derivative . Drugs cause significant nephrotoxicity hepatotoxicity . Immunomodulating agent , include pharmacologic dos steroid &gt; 10 day . Excluded within 4 week study entry : Interferon . Isoprinosine . IL2 . Excluded within 8 week study entry : Antiretroviral agent , include ribavirin , dideoxycytidine , dideoxyadenosine , didanosine , foscarnet , dextran sulfate , AL721 . Prior Treatment : Excluded : Radiation therapy ( exception electron beam therapy area le 100 cm2 ) . Experimental therapy . Cytolytic chemotherapy . Active drug alcohol abuse .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 1990</verification_date>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Zidovudine</keyword>
</DOC>